Fady Ibraham Malik Sells $220K of Cytokinetics Inc (CYTK) — SEC Form 4, Nov 03, 2026
Open-Market Net Sale · SEC Form 4
−$220,255
10b5-1 Plan
Equity Position
157K sh
157,402 → 157,402
Filing Lag
0 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Fady Ibraham Malik CIK 0001551778 |
EVP
|
Fady Ibraham Malik at Cytokinetics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$4,933,515
More from this insider at Cytokinetics Inc
| 2026-10-20 | Sell | -$224,035 | View |
| 2026-10-06 | Sell | -$214,830 | View |
| 2026-09-22 | Sell | -$239,015 | View |
| 2026-09-08 | Sell | -$264,110 | View |
| 2026-08-18 | Sell | -$265,370 | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-11-03 | M - Exercise 10b5-1 | 3,500 A | $7.80 | +$27,300 | 157,402 | Direct |
| Common Stock | 2026-11-03 | S - Sale 10b5-1 | 3,500 D | $62.93 | -$220,255 | 153,902 | Direct |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy) | $7.80 | 2026-11-03 | M - Exercise 10b5-1 | 3,500 D | $0.00 | 2028-02-27 | 3,500 Common Stock | Direct |
Related filings at Cytokinetics Inc
Institutional Holders
13F holders · Jun 30, 2026
486
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $1.71B
- T. Rowe Price Investment Management, Inc. $1.59B
- Wellington Management Group Llp $591M
5%+ Holders · 13D/G
4 filers
Other insiders at Cytokinetics Inc
GET /v1/forms/4/0001061983-26-000108
API docs
View Original SEC Filing